Home
#Global Trends
#Vietnam
#M&A
#Regulations
#Knowledge
Newletter
Events

Home
#Global Trends
#Vietnam
#M&A
#Regulations
#Knowledge
Newletter
Events

Category: Uncategorized

Manufacturing Calibration Deficits: Lam Dong Health Authorities Seal Ladophar’s Artichoke Drug Over Volume Discrepancy

01/07/2026 Published by Pharma Biz

Key Development The Department of Health of Lam Dong Province has formally issued an emergency regulatory mandate requiring the immediate... Read more

Tags: #Vietnam

Decentralizing High-Acute Care: Viet Duc Hospital’s Multimillion-Dollar Facility No. 2 Poised for Launch on July 10

01/07/2026 Published by Pharma Biz

Key Development The Minister of Health of Vietnam, Dao Hong Lan, has officially mandated the immediate deployment of comprehensive execution... Read more

Category: Uncategorized

Tags: #Vietnam

The Multi-Billion Orphan Product Transition: Analyzing AstraZeneca’s Phase III Data for Efzimfotase Alfa in Bone Disease

30/06/2026 Published by Pharma Biz

Key Development AstraZeneca, through its core rare disease operational arm Alexion, has officially unveiled detailed high-level data from its pivotal... Read more

Category: Uncategorized

Tags: #Global Trends

Late-Stage Asset Crystallization: Analyzing Ipsen’s $1.7 Billion Strategic Acquisition of Kartos Therapeutics

30/06/2026 Published by Pharma Biz

Key Development Global biopharmaceutical leader Ipsen (Euronext: IPN; ADR: IPSEY) has formally entered into a definitive merger agreement to acquire... Read more

Category: Uncategorized

Tags: #Global Trends

The GLP-1 Warfare in China: Pfizer and Innovent Clear Preliminary National Insurance Hurdles for a Billion-Citizen Market

30/06/2026 Published by Pharma Biz

Key Development China's National Healthcare Security Administration (NHSA) has officially released its updated regulatory ledger showing that next-generation GLP-1 receptor... Read more

Category: Uncategorized

Tags: #Global Trends

Disrupting the Genomics Monopoly: Analyzing Roche’s Strategic Deployment of Axelios to Challenge Illumina

30/06/2026 Published by Pharma Biz

Key Development Swiss healthcare and diagnostics powerhouse Roche has officially launched its next-generation gene sequencing platform, Axelios, marking an aggressive... Read more

Category: Uncategorized

Tags: #Global Trends

Accelerating the Onshoring Wave: FDA Enrolls Eli Lilly and Regeneron in Landmark Real-Time Construction Review Pilot

30/06/2026 Published by Pharma Biz

Key Development The U.S. Food and Drug Administration (FDA) has officially announced the selection of seven pioneering pharmaceutical and biotechnology... Read more

Category: Uncategorized

Tags: #Global Trends

Institutional Capital Hedging via Royalty Consolidation: Analyzing Zymeworks’ $929 Million Takeover of Theravance

30/06/2026 Published by Pharma Biz

Key Development Global oncology therapeutics specialist Zymeworks (Vancouver, Canada) has entered into a definitive merger agreement to acquire the distressed... Read more

Category: Uncategorized

Tags: #M&A

The $4 Billion VMS Bidding War: Unilever and Haleon Counter-Bid for L Catterton’s High-Growth Asset, Thorne

30/06/2026 Published by Pharma Biz

Key Development The global consumer health and wellness ecosystem has transformed into a high-stakes corporate battlefield as fast-moving consumer goods... Read more

Category: Uncategorized

Tags: #M&A

Posts pagination

Previous page Page 1 … Page 65 Page 66 Page 67 … Page 226 Next page

Facebook

Map

Workday: Monday to Friday
Working hours: 8am to 5pm
Address: 8th floor, Hyco 4 building, 205A Nguyen Xi Street, Binh Thanh Ward, HCMC

Please enable JavaScript in your browser to complete this form.

Email

Email *

Get Your Weekly Market Insights Stay informed on Vietnam's market & Healthcare Alliance updates

Category: Uncategorized

Facebook

Map

Online Members